616 related articles for article (PubMed ID: 30278282)
21. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and bioactivities of Celecoxib analogues or derivatives.
Zhou S; Yang S; Huang G
Bioorg Med Chem; 2017 Sep; 25(17):4887-4893. PubMed ID: 28757100
[TBL] [Abstract][Full Text] [Related]
23. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
Unsal-Tan O; Ozadali K; Piskin K; Balkan A
Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
26. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
[TBL] [Abstract][Full Text] [Related]
27. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic Liability.
Gouda AM; Ali HI; Almalki WH; Azim MA; Abourehab MA; Abdelazeem AH
Molecules; 2016 Feb; 21(2):. PubMed ID: 26867188
[TBL] [Abstract][Full Text] [Related]
29. New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.
Dawood DH; Batran RZ; Farghaly TA; Khedr MA; Abdulla MM
Arch Pharm (Weinheim); 2015 Dec; 348(12):875-88. PubMed ID: 26462142
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
[TBL] [Abstract][Full Text] [Related]
31. Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities.
Abdellatif KRA; Fadaly WAA; Mostafa YA; Zaher DM; Omar HA
Bioorg Chem; 2019 Oct; 91():103132. PubMed ID: 31374529
[TBL] [Abstract][Full Text] [Related]
32. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Bakr RB; Ghoneim AA; Azouz AA
Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
[TBL] [Abstract][Full Text] [Related]
33. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.
Metwally NH; Mohamed MS
Bioorg Chem; 2020 Jun; 99():103438. PubMed ID: 31796216
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
Firke SD; Bari SB
Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
[TBL] [Abstract][Full Text] [Related]
35. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
[TBL] [Abstract][Full Text] [Related]
36. Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study.
Lamie PF; Philoppes JN; Azouz AA; Safwat NM
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):805-820. PubMed ID: 28587532
[TBL] [Abstract][Full Text] [Related]
37. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Alsayed SS; Elshemy HA; Abdelgawad MA; Abdel-Latif MS; Abdellatif KR
Bioorg Chem; 2017 Feb; 70():173-183. PubMed ID: 28057325
[TBL] [Abstract][Full Text] [Related]
39. Benzofuran-selenadiazole hybrids as novel α-glucosidase and cyclooxygenase-2 inhibitors with antioxidant and cytotoxic properties.
Olomola TO; Mphahlele MJ; Gildenhuys S
Bioorg Chem; 2020 Jul; 100():103945. PubMed ID: 32450390
[TBL] [Abstract][Full Text] [Related]
40. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]